Stemtech annual operating margin
2021
2022
2023
2024
2025
Stemtech's operating margin was −94.18% for fiscal 2025.
View full Stemtech company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −94.18% | −46.96 pp |
| 2024 | 2024-12-31 | −47.22% | +38.62 pp |
| 2023 | 2023-12-31 | −85.84% | +24.34 pp |
| 2022 | 2022-12-31 | −110.18% | −35.89 pp |
| 2021 | 2021-12-31 | −74.29% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −19.95% | +23.17 pp |
| Q1 2026 | 2026-03-31 | −236.36% | −97.55 pp |
| Q4 2025 | 2025-12-31 | −188.59% | −191.11 pp |
| Q3 2025 | 2025-09-30 | −39.80% | +29.65 pp |
| Q2 2025 | 2025-06-30 | −43.13% | +9.09 pp |
| Q1 2025 | 2025-03-31 | −138.81% | −65.70 pp |
| Q4 2024 | 2024-12-31 | 2.52% | +107.31 pp |
| Q3 2024 | 2024-09-30 | −69.45% | −24.85 pp |
| Q2 2024 | 2024-06-30 | −52.22% | +33.55 pp |
| Q1 2024 | 2024-03-31 | −73.11% | +37.27 pp |
| Q4 2023 | 2023-12-31 | −104.79% | −64.75 pp |
| Q3 2023 | 2023-09-30 | −44.60% | +278.45 pp |
| Q2 2023 | 2023-06-30 | −85.77% | −5.22 pp |
| Q1 2023 | 2023-03-31 | −110.38% | −94.77 pp |
| Q4 2022 | 2022-12-31 | −40.04% | +41.01 pp |
| Q3 2022 | 2022-09-30 | −323.05% | −266.64 pp |
| Q2 2022 | 2022-06-30 | −80.55% | −73.57 pp |
| Q1 2022 | 2022-03-31 | −15.61% | −39.68 pp |
| Q3 2021 · Sep 30 | 2021-09-30 | −81.04% | — |
| Q3 2021 · Jun 30 | 2021-06-30 | −56.41% | — |
| Q2 2021 · Mar 31 | 2021-03-31 | −6.98% | — |
| Q3 2021 · Sep 30 | 2020-09-30 | 24.07% | — |
Across the available reported history, Stemtech's operating margin decreased from −47.22% to −94.18%, a change of −46.96 percentage points. The latest reported quarter, Q2 2026, shows −19.95%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Stemtech filings at SEC.gov ↗